Plunkett Research Online: Eloxx Pharmaceuticals

ELOXX PHARMACEUTICALS (ELOX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing novel ribonucleic acid (RNA)-modulating drug candidates that are formulated to treat rare and ultra-rare premature stop codon diseases. The ELX-02, the company's lead investigational drug product candidate, is a small.....


ELOXX PHARMACEUTICALS

Ticker: ELOX
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 781 577-5300
Fax:
Address: 950 Winter Street
Waltham, MA 02451 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Sumit AggarwalCEO/Director/President
Daniel GeffkenCFO/Chief Accounting Officer
See More
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing novel ribonucleic acid (RNA)-modulating drug candidates that are formulated to treat rare and ultra-rare premature stop codon diseases. The ELX-02, the company's lead investigational drug product candidate, is a small.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture